Bellevue Group
Latest statistics and disclosures from Bellevue Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IONS, ARGX, NBIX, VRTX, MRNA, and represent 21.83% of Bellevue Group's stock portfolio.
- Added to shares of these 10 stocks: INCY (+$17M), ISRG (+$16M), DXCM (+$15M), CNC (+$14M), ABT (+$13M), FATE (+$11M), MGNX (+$11M), OM (+$11M), HCA (+$11M), IONS (+$11M).
- Started 8 new stock positions in RCKT, NTRA, ISEE, NVCR, KRTX, ARWR, ALKS, BLU.
- Reduced shares in these 10 stocks: Abiomed (-$41M), UNH (-$38M), HZNP (-$33M), ELV (-$27M), MOH (-$18M), VRTX (-$18M), AXNX (-$18M), LEGN (-$14M), HUM (-$12M), JAZZ (-$11M).
- Sold out of its positions in Abiomed, Avalara, CRBU, CTLT, NVST, NTLA, EL, NPCE, LUNG, RLMD. RGEN, SWKS, ZTS.
- Bellevue Group was a net seller of stock by $-9.3M.
- Bellevue Group has $7.5B in assets under management (AUM), dropping by 8.14%.
- Central Index Key (CIK): 0001674546
Tip: Access up to 7 years of quarterly data
Positions held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bellevue Group
Bellevue Group holds 171 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals (IONS) | 4.9 | $368M | +2% | 9.7M | 37.77 |
|
| Argenx Se Sponsored Adr (ARGX) | 4.6 | $345M | 911k | 378.83 |
|
|
| Neurocrine Biosciences (NBIX) | 4.4 | $331M | -2% | 2.8M | 119.44 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.2 | $317M | -5% | 1.1M | 288.78 |
|
| Moderna (MRNA) | 3.8 | $284M | 1.6M | 179.62 |
|
|
| Intuitive Surgical Com New (ISRG) | 3.4 | $254M | +6% | 957k | 265.35 |
|
| Incyte Corporation (INCY) | 3.2 | $238M | +7% | 3.0M | 80.32 |
|
| Alnylam Pharmaceuticals (ALNY) | 2.9 | $219M | -3% | 921k | 237.65 |
|
| Abbott Laboratories (ABT) | 2.5 | $185M | +7% | 1.7M | 109.79 |
|
| Boston Scientific Corporation (BSX) | 2.4 | $181M | +2% | 3.9M | 46.27 |
|
| Intra Cellular Therapies (ITCI) | 2.3 | $177M | 3.3M | 52.92 |
|
|
| Myovant Sciences | 2.1 | $159M | 5.9M | 26.96 |
|
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.6 | $121M | -8% | 757k | 159.31 |
|
| Stryker Corporation (SYK) | 1.6 | $120M | +3% | 492k | 244.49 |
|
| Axonics Modulation Technolog (AXNX) | 1.6 | $119M | -13% | 1.9M | 62.53 |
|
| UnitedHealth (UNH) | 1.6 | $119M | -24% | 224k | 530.18 |
|
| Revolution Medicines (RVMD) | 1.5 | $116M | +3% | 4.9M | 23.82 |
|
| Agios Pharmaceuticals (AGIO) | 1.5 | $114M | 4.1M | 28.08 |
|
|
| Sage Therapeutics (SAGE) | 1.5 | $113M | 3.0M | 38.14 |
|
|
| Dex (DXCM) | 1.5 | $112M | +14% | 989k | 113.24 |
|
| Insulet Corporation (PODD) | 1.4 | $102M | -7% | 346k | 294.39 |
|
| Inspire Med Sys (INSP) | 1.3 | $101M | 402k | 251.88 |
|
|
| Danaher Corporation (DHR) | 1.3 | $97M | 366k | 265.42 |
|
|
| Sarepta Therapeutics (SRPT) | 1.2 | $90M | -8% | 693k | 129.58 |
|
| Becton, Dickinson and (BDX) | 1.1 | $84M | 332k | 254.30 |
|
|
| Tandem Diabetes Care Com New (TNDM) | 1.1 | $81M | +14% | 1.8M | 44.95 |
|
| Celldex Therapeutics Com New (CLDX) | 1.1 | $80M | 1.8M | 44.57 |
|
|
| Hca Holdings (HCA) | 1.1 | $80M | +15% | 331k | 239.96 |
|
| Edwards Lifesciences (EW) | 1.1 | $79M | +3% | 1.1M | 74.61 |
|
| Anthem (ELV) | 1.0 | $77M | -26% | 149k | 512.97 |
|
| Arvinas Ord (ARVN) | 1.0 | $74M | 2.2M | 34.21 |
|
|
| Outset Med (OM) | 1.0 | $73M | +17% | 2.8M | 25.82 |
|
| Option Care Health Com New (OPCH) | 1.0 | $73M | -7% | 2.4M | 30.09 |
|
| Insmed Com Par $.01 (INSM) | 0.9 | $66M | 3.3M | 19.98 |
|
|
| EXACT Sciences Corporation (EXAS) | 0.9 | $65M | +16% | 1.3M | 49.51 |
|
| Charles River Laboratories (CRL) | 0.8 | $63M | +10% | 290k | 217.90 |
|
| Relay Therapeutics (RLAY) | 0.8 | $63M | 4.2M | 14.94 |
|
|
| Molina Healthcare (MOH) | 0.8 | $61M | -22% | 186k | 330.22 |
|
| Macrogenics (MGNX) | 0.8 | $60M | +22% | 9.0M | 6.71 |
|
| Apellis Pharmaceuticals (APLS) | 0.8 | $57M | +9% | 1.1M | 51.71 |
|
| Centene Corporation (CNC) | 0.8 | $57M | +31% | 694k | 82.01 |
|
| Humana (HUM) | 0.8 | $57M | -17% | 111k | 512.19 |
|
| Evolent Health Cl A (EVH) | 0.7 | $56M | +6% | 2.0M | 28.08 |
|
| Silk Road Medical Inc Common (SILK) | 0.7 | $54M | -3% | 1.0M | 52.85 |
|
| Pacific Biosciences of California (PACB) | 0.7 | $53M | +19% | 6.5M | 8.18 |
|
| Cigna Corp (CI) | 0.7 | $53M | -15% | 159k | 331.34 |
|
| Amedisys (AMED) | 0.7 | $51M | +2% | 614k | 83.54 |
|
| Shockwave Med (SWAV) | 0.7 | $51M | -10% | 248k | 205.61 |
|
| Globus Med Cl A (GMED) | 0.7 | $51M | +5% | 680k | 74.27 |
|
| Penumbra (PEN) | 0.7 | $50M | +18% | 226k | 222.46 |
|
| Fate Therapeutics (FATE) | 0.7 | $49M | +29% | 4.9M | 10.09 |
|
| Medtronic SHS (MDT) | 0.6 | $48M | 618k | 77.72 |
|
|
| Bio Rad Labs Cl A (BIO) | 0.6 | $47M | +9% | 111k | 420.49 |
|
| Halozyme Therapeutics (HALO) | 0.6 | $46M | -12% | 813k | 56.90 |
|
| Thermo Fisher Scientific (TMO) | 0.6 | $46M | +15% | 83k | 550.69 |
|
| IDEXX Laboratories (IDXX) | 0.6 | $44M | 109k | 407.96 |
|
|
| Exelixis (EXEL) | 0.6 | $43M | 2.7M | 16.04 |
|
|
| Transmedics Group (TMDX) | 0.6 | $42M | +4% | 682k | 61.72 |
|
| Pfizer (PFE) | 0.5 | $40M | +2% | 789k | 51.24 |
|
| Iqvia Holdings (IQV) | 0.5 | $38M | +14% | 183k | 204.89 |
|
| Crispr Therapeutics Namen Akt (CRSP) | 0.5 | $37M | 912k | 40.65 |
|
|
| Caredx (CDNA) | 0.5 | $36M | +21% | 3.2M | 11.41 |
|
| Zimmer Holdings (ZBH) | 0.5 | $34M | 266k | 127.50 |
|
|
| Axsome Therapeutics (AXSM) | 0.4 | $34M | -12% | 437k | 77.13 |
|
| Biontech Se Sponsored Ads (BNTX) | 0.4 | $33M | +43% | 221k | 150.22 |
|
| Harmony Biosciences Hldgs In (HRMY) | 0.4 | $33M | -9% | 596k | 55.10 |
|
| Wave Life Sciences SHS (WVE) | 0.4 | $32M | 4.5M | 7.00 |
|
|
| Procept Biorobotics Corp (PRCT) | 0.4 | $31M | +25% | 742k | 41.54 |
|
| Veeva Sys Cl A Com (VEEV) | 0.4 | $30M | +18% | 186k | 161.38 |
|
| Accolade (ACCD) | 0.4 | $29M | +2% | 3.7M | 7.79 |
|
| AtriCure (ATRC) | 0.4 | $29M | 644k | 44.38 |
|
|
| Hutchmed China Sponsored Ads (HCM) | 0.4 | $28M | 1.8M | 15.97 |
|
|
| Beam Therapeutics (BEAM) | 0.4 | $27M | +21% | 697k | 39.11 |
|
| Esperion Therapeutics (ESPR) | 0.4 | $27M | +2% | 4.3M | 6.23 |
|
| Cooper Cos Com New (COO) | 0.4 | $27M | 81k | 330.67 |
|
|
| Omnicell (OMCL) | 0.3 | $26M | +25% | 518k | 50.42 |
|
| Mersana Therapeutics (MRSN) | 0.3 | $25M | +4% | 4.3M | 5.86 |
|
| Adaptive Biotechnologies Cor (ADPT) | 0.3 | $23M | -9% | 3.0M | 7.64 |
|
| Castle Biosciences (CSTL) | 0.3 | $22M | 944k | 23.54 |
|
|
| Phreesia (PHR) | 0.3 | $22M | 666k | 32.36 |
|
|
| Kezar Life Sciences (KZR) | 0.3 | $21M | 3.0M | 7.04 |
|
|
| Privia Health Group (PRVA) | 0.3 | $21M | +74% | 901k | 22.71 |
|
| ResMed (RMD) | 0.3 | $21M | +16% | 98k | 208.13 |
|
| Essa Pharma Com New (EPIX) | 0.3 | $20M | +33% | 7.9M | 2.52 |
|
| Scholar Rock Hldg Corp (SRRK) | 0.3 | $20M | 2.2M | 9.05 |
|
|
| Illumina (ILMN) | 0.3 | $19M | +10% | 95k | 202.20 |
|
| CVS Caremark Corporation (CVS) | 0.3 | $19M | -9% | 204k | 93.19 |
|
| Hologic (HOLX) | 0.2 | $18M | -3% | 243k | 74.81 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.2 | $18M | -43% | 355k | 49.92 |
|
| Align Technology (ALGN) | 0.2 | $17M | +5% | 79k | 210.90 |
|
| Baxter International (BAX) | 0.2 | $16M | 321k | 50.97 |
|
|
| Doximity Cl A (DOCS) | 0.2 | $15M | +131% | 449k | 33.56 |
|
| Generation Bio (GBIO) | 0.2 | $14M | 3.6M | 3.93 |
|
|
| 10x Genomics Cl A Com (TXG) | 0.2 | $12M | +27% | 325k | 36.44 |
|
| Regeneron Pharmaceuticals (REGN) | 0.2 | $11M | -9% | 16k | 721.49 |
|
| Gilead Sciences (GILD) | 0.1 | $11M | +33% | 130k | 85.85 |
|
| Nevro (NVRO) | 0.1 | $10M | 261k | 39.60 |
|
|
| Amgen (AMGN) | 0.1 | $10M | -13% | 39k | 262.64 |
|
| Avantor (AVTR) | 0.1 | $9.9M | -6% | 472k | 21.09 |
|
| Black Diamond Therapeutics (BDTX) | 0.1 | $9.7M | +14% | 5.4M | 1.80 |
|
| Teladoc (TDOC) | 0.1 | $9.2M | 390k | 23.65 |
|
|
| Biogen Idec (BIIB) | 0.1 | $7.9M | 28k | 276.92 |
|
|
| Beigene Sponsored Adr (BGNE) | 0.1 | $7.7M | +392% | 35k | 223.62 |
|
| Natera (NTRA) | 0.1 | $7.0M | NEW | 174k | 40.17 |
|
| Dr Reddys Labs Adr (RDY) | 0.1 | $6.4M | +912% | 126k | 51.24 |
|
| Olink Hldg Ab Sponsored Ads (OLK) | 0.1 | $6.4M | +8% | 251k | 25.38 |
|
| BioMarin Pharmaceutical (BMRN) | 0.1 | $6.3M | +13% | 61k | 103.49 |
|
| Teleflex Incorporated (TFX) | 0.1 | $6.3M | -20% | 25k | 249.63 |
|
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $5.6M | -54% | 1.3M | 4.32 |
|
| American Well Corp Cl A (AMWL) | 0.1 | $5.5M | +10% | 2.0M | 2.83 |
|
| Astrazeneca Sponsored Adr (AZN) | 0.1 | $4.6M | +54% | 69k | 67.86 |
|
| Johnson & Johnson (JNJ) | 0.1 | $4.6M | -15% | 26k | 176.65 |
|
| Eli Lilly & Co. (LLY) | 0.1 | $4.0M | +16% | 11k | 365.84 |
|
| Supernus Pharmaceuticals (SUPN) | 0.1 | $4.0M | -6% | 111k | 35.67 |
|
| Molecular Templates (MTEM) | 0.0 | $3.7M | 11M | 0.33 |
|
|
| Guardant Health (GH) | 0.0 | $3.7M | +118% | 136k | 27.20 |
|
| Bristol Myers Squibb (BMY) | 0.0 | $3.6M | +611% | 50k | 71.95 |
|
| Sight Sciences (SGHT) | 0.0 | $3.6M | 295k | 12.21 |
|
|
| Seagen (SGEN) | 0.0 | $2.9M | -47% | 23k | 128.51 |
|
| Zai Lab Adr (ZLAB) | 0.0 | $2.8M | +145% | 90k | 31.53 |
|
| Abbvie (ABBV) | 0.0 | $2.6M | -4% | 16k | 161.61 |
|
| Cytokinetics Com New (CYTK) | 0.0 | $2.5M | -23% | 54k | 45.82 |
|
| Akero Therapeutics (AKRO) | 0.0 | $2.3M | +2% | 43k | 54.80 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.0 | $2.1M | -28% | 70k | 29.60 |
|
| Homology Medicines (FIXX) | 0.0 | $2.0M | 1.6M | 1.26 |
|
|
| Kosmos Energy (KOS) | 0.0 | $2.0M | 318k | 6.36 |
|
|
| AmerisourceBergen (ABC) | 0.0 | $1.7M | -14% | 10k | 165.71 |
|
| Alkermes SHS (ALKS) | 0.0 | $1.6M | NEW | 36k | 44.53 |
|
| Krystal Biotech (KRYS) | 0.0 | $1.4M | 18k | 79.22 |
|
|
| Karuna Therapeutics Ord (KRTX) | 0.0 | $1.4M | NEW | 7.3k | 196.50 |
|
| Horizon Therapeutics Pub L SHS (HZNP) | 0.0 | $1.4M | -95% | 12k | 113.80 |
|
| Arcus Biosciences Incorporated (RCUS) | 0.0 | $1.4M | -21% | 66k | 20.68 |
|
| Miragen Therapeutics (VRDN) | 0.0 | $1.3M | 46k | 29.21 |
|
|
| Agilent Technologies Inc C ommon (A) | 0.0 | $1.2M | -7% | 8.0k | 149.65 |
|
| McKesson Corporation (MCK) | 0.0 | $1.1M | 2.9k | 375.12 |
|
|
| Berkeley Lts (CELL) | 0.0 | $1.0M | 385k | 2.68 |
|
|
| Iveric Bio (ISEE) | 0.0 | $895k | NEW | 42k | 21.41 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.0 | $864k | NEW | 21k | 40.56 |
|
| Denali Therapeutics (DNLI) | 0.0 | $862k | 31k | 27.81 |
|
|
| Cardinal Health (CAH) | 0.0 | $815k | +1054% | 11k | 76.87 |
|
| Seer Com Cl A (SEER) | 0.0 | $790k | 136k | 5.80 |
|
|
| Laboratory Corp Amer Hldgs Com New (LH) | 0.0 | $784k | -14% | 3.3k | 235.48 |
|
| Merck & Co (MRK) | 0.0 | $749k | +39% | 6.8k | 110.95 |
|
| Inhibrx (INBX) | 0.0 | $732k | -31% | 30k | 24.64 |
|
| Rocket Pharmaceuticals (RCKT) | 0.0 | $716k | NEW | 37k | 19.57 |
|
| Merus N V (MRUS) | 0.0 | $707k | +79% | 46k | 15.47 |
|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 0.0 | $688k | 1.8k | 382.43 |
|
|
| Xencor (XNCR) | 0.0 | $661k | 25k | 26.04 |
|
|
| Novocure Ord Shs (NVCR) | 0.0 | $660k | NEW | 9.0k | 73.33 |
|
| Alphabet Cap Stk Cl C (GOOG) | 0.0 | $532k | 6.0k | 88.73 |
|
|
| Spdr Ser Tr S&p Oilgas Exp (XOP) | 0.0 | $530k | 3.9k | 135.88 |
|
|
| Vaneck Etf Trust Gold Miners Etf (GDX) | 0.0 | $527k | +37% | 18k | 28.66 |
|
| Bellus Health Com New (BLU) | 0.0 | $369k | NEW | 45k | 8.22 |
|
| Design Therapeutics (DSGN) | 0.0 | $358k | 35k | 10.26 |
|
|
| Opthea Sponsored Ads (OPT) | 0.0 | $235k | 47k | 4.99 |
|
|
| Ishares Tr Msci China Etf (MCHI) | 0.0 | $195k | 4.1k | 47.50 |
|
|
| MarketAxess Holdings (MKTX) | 0.0 | $185k | 662.00 | 278.89 |
|
|
| Vaneck Etf Trust Junior Gold Mine (GDXJ) | 0.0 | $178k | 5.0k | 35.65 |
|
|
| MercadoLibre (MELI) | 0.0 | $144k | 170.00 | 846.24 |
|
|
| Dolby Laboratories Com Cl A (DLB) | 0.0 | $113k | 1.6k | 70.54 |
|
|
| Acadia Healthcare (ACHC) | 0.0 | $106k | +42% | 1.3k | 82.32 |
|
| IPG Photonics Corporation (IPGP) | 0.0 | $99k | 1.1k | 94.67 |
|
|
| United Therapeutics Corporation (UTHR) | 0.0 | $59k | -29% | 212.00 | 278.09 |
|
| Jumia Technologies Sponsored Ads (JMIA) | 0.0 | $58k | 18k | 3.21 |
|
|
| Nektar Therapeutics (NKTR) | 0.0 | $33k | 15k | 2.26 |
|
|
| Equinix (EQIX) | 0.0 | $26k | 40.00 | 655.02 |
|
|
| Evertec (EVTC) | 0.0 | $24k | 739.00 | 32.38 |
|
|
| Infosys Sponsored Adr (INFY) | 0.0 | $21k | 1.1k | 18.24 |
|
|
| United Microelectronics Corp Spon Adr New (UMC) | 0.0 | $18k | 2.7k | 6.62 |
|
|
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 0.0 | $1.2k | 770.00 | 1.62 |
|
|
| Grupo Aeroportuario Del Sure Spon Adr Ser B (ASR) | 0.0 | $157.005000 | 135.00 | 1.16 |
|
Past Filings by Bellevue Group
SEC 13F filings are viewable for Bellevue Group going back to 2016
- Bellevue Group 2022 Q4 filed Feb. 14, 2023
- Bellevue Group 2022 Q3 filed Nov. 14, 2022
- Bellevue Group 2022 Q2 filed Aug. 11, 2022
- Bellevue Group 2022 Q1 filed May 13, 2022
- Bellevue Group 2021 Q4 filed Feb. 10, 2022
- Bellevue Group 2021 Q3 filed Nov. 12, 2021
- Bellevue Group 2021 Q2 filed Aug. 12, 2021
- Bellevue Group 2021 Q1 filed May 12, 2021
- Bellevue Group 2020 Q4 filed Feb. 16, 2021
- Bellevue Group 2020 Q3 filed Nov. 16, 2020
- Bellevue Group 2020 Q2 filed Aug. 13, 2020
- Bellevue Group 2020 Q1 filed May 14, 2020
- Bellevue Group 2019 Q4 filed Feb. 14, 2020
- Bellevue Group 2019 Q3 filed Nov. 14, 2019
- Bellevue Group 2019 Q2 filed Aug. 14, 2019
- Bellevue Group 2019 Q1 filed May 15, 2019